Gh. Fisher et al., FREE D-AMINO ACIDS IN HUMAN CEREBROSPINAL-FLUID OF ALZHEIMER-DISEASE,MULTIPLE-SCLEROSIS, AND HEALTHY CONTROL SUBJECTS, Molecular and chemical neuropathology, 23(2-3), 1994, pp. 115-124
This is the first report of the presence of free D-amino acids in lumb
ar and ventricular human cerebrospinal fluid (CSF) of individuals with
Alzheimer disease (AD) compared with CSF of normal control subjects a
nd with individuals affected by multiple sclerosis, as an unrelated ne
urologic disorder. Free D-amino acids are present at significantly hig
her levels in AD CSF than normal CSF, whereas in the CSF of patients a
ffected by multiple sclerosis, D-amino acids occurs at the same level
as in the normal controls. The total D-amino acid content in ventricul
ar CSF was 1.48 times higher in the AD than controls (26.4 vs 17.9 nmo
l/ml, p = 0.025). The total D-amino acid content was 1.43 times higher
in AD lumbar CSF than controls (1.89 vs 1.32 nmol/mL, p = 0.001). D-A
spartate in particular was 2.74 times higher in AD ventricular CSF com
pared to normal ventricular CSF (3.34 vs 1.22 nmol/mL, p = 0.029). In
lumbar CSF, D-aspartate was 1.5 times higher in AD than controls (0.05
4 vs 0.036 nmol/mL, p = 0.041). Previously we reported that D-amino ac
ids are elevated in AD brain proteins associated with neurofibrillary
tangles compared to normal brain proteins (D'Aniello et al., 1992c; Fi
sher et al., 1992a,b). Thus, the D-amino acids present in CSF may orig
inate from degradation of brain proteins.